PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
2.740
+0.020 (0.74%)
Mar 31, 2025, 9:30 AM EDT - Market open
PolyPid Market Cap
PolyPid has a market cap or net worth of $27.92 million as of March 31, 2025. Its market cap has decreased by -9.05% in one year.
Market Cap
27.92M
Enterprise Value
21.90M
1-Year Change
-9.05%
Ranking
Category
Stock Price
$2.74
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has decreased from $82.43M to $27.92M, a decrease of -66.13%. That is a compound annual growth rate of -20.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 27.92M | 35.01% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | 183.09M | 122.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |